» Articles » PMID: 36753415

CRISPR Screening Reveals a Dependency on Ribosome Recycling for Efficient SARS-CoV-2 Programmed Ribosomal Frameshifting and Viral Replication

Overview
Journal Cell Rep
Publisher Cell Press
Date 2023 Feb 8
PMID 36753415
Authors
Affiliations
Soon will be listed here.
Abstract

During translation of the genomic RNA of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus in the COVID-19 pandemic, host ribosomes undergo programmed ribosomal frameshifting (PRF) at a conserved structural element. Although PRF is essential for coronavirus replication, host factors that regulate this process have not yet been identified. Here we perform genome-wide CRISPR-Cas9 knockout screens to identify regulators of SARS-CoV-2 PRF. These screens reveal that loss of ribosome recycling factors markedly decreases frameshifting efficiency and impairs SARS-CoV-2 viral replication. Mutational studies support a model wherein efficient removal of ribosomal subunits at the ORF1a stop codon is required for frameshifting of trailing ribosomes. This dependency upon ribosome recycling is not observed with other non-pathogenic human betacoronaviruses and is likely due to the unique position of the ORF1a stop codon in the SARS clade of coronaviruses. These findings therefore uncover host factors that support efficient SARS-CoV-2 translation and replication.

Citing Articles

Biological Significance and Therapeutic Promise of Programmed Ribosomal Frameshifting.

Ramamonjiharisoa M, Liu S Int J Mol Sci. 2025; 26(3).

PMID: 39941062 PMC: 11818727. DOI: 10.3390/ijms26031294.


MCTS2 and distinct eIF2D roles in uORF-dependent translation regulation revealed by in vitro re-initiation assays.

Meurs R, De Matos M, Bothe A, Guex N, Weber T, Teleman A EMBO J. 2025; 44(3):854-876.

PMID: 39748120 PMC: 11790910. DOI: 10.1038/s44318-024-00347-3.


Viral RNA Interactome: The Ultimate Researcher's Guide to RNA-Protein Interactions.

Hanson W, Romero Agosto G, Rouskin S Viruses. 2024; 16(11).

PMID: 39599817 PMC: 11599142. DOI: 10.3390/v16111702.


A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist.

Le Pen J, Paniccia G, Kinast V, Moncada-Velez M, Ashbrook A, Bauer M PLoS Biol. 2024; 22(9):e3002767.

PMID: 39316623 PMC: 11486371. DOI: 10.1371/journal.pbio.3002767.


Genome-scale CRISPR-Cas9 screen identifies host factors as potential therapeutic targets for SARS-CoV-2 infection.

Sakai M, Masuda Y, Tarumoto Y, Aihara N, Tsunoda Y, Iwata M iScience. 2024; 27(8):110475.

PMID: 39100693 PMC: 11295705. DOI: 10.1016/j.isci.2024.110475.